Financials
- Market Capitalization 21.65 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.05
Rapporto prezzo/fatturato
-280.95
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4592 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.33 USD | -0.47% | +7.29% | +19.43% | -35.34% | 21.93 M USD | ||
| 4595 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.65 USD | -1.52% | 0.00% | 0.00% | -50.76% | 21.68 M USD | ||
| 4599 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.69 USD | +2.28% | +0.37% | +16.96% | -14.33% | 21.50 M USD | ||
| 4602 | SKYE Skye Bioscience, Inc. - Common Stock | 0.61 USD | -7.58% | -15.28% | -22.78% | -23.75% | 21.44 M USD |